Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Multiple Myeloma Therapeutics - US Market Trends' returned 3 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Multiple Myeloma Partnering 2007-2012   CurrentPartnering, May 2012, Pages: 150 to derive value from the deal. The initial chapters of this report provide an orientation of multiple myeloma partnering trends. Chapter 1 provides an introduction to the report, whilst chapter 2 provides Oncology Partnering Agreements in Pharma, Biotech and Diagnostics   CurrentPartnering, June 2009, Pages: 471 Gastrointestinal Head and neck Kidney Leukemia Liver Lung Lymphoma Melanoma Multiple myeloma Ovarian Pancreatic Prostate Solid tumour Broad focus Diagnostics Drug delivery Chapter 7 – Oncology partnering resource Drugs in the Pipeline--An R&D Analysis   Frost & Sullivan, March 2004 in the cardiovasular, central nervous system, and cancer therapeutic areas. Analysis of the technological trends, drivers, challenges, and recent developments assists in creating effective R&D, marketing and production Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network